Mice engineered to express a c-Cbl RING domain point mutation (C379A) develop a myeloproliferative disease that progresses to leukemia [41], thus classifying c-Cbl mutations as driver mutations. The gene discussed is CBL; the disease is myeloproliferative disorder.